FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 334:864-865 March 28, 1996 Number 13 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Fine, J.-D. Related Article by Roujeau, J.-C.

To the Editor: On the basis of personal experience and "in the hope that very early intervention . . . in a patient with still relatively limited involvement . . . may prevent more extensive epidermal necrosis," Fine (Nov. 30 issue)¹ recommends systemic corticosteroid therapy in patients with toxic epidermal necrolysis. We have argued against the use of this therapy.² This difference of opinion reflects the absence of well-controlled evaluations of corticosteroid therapy in such patients.

The arguments for the use of corticosteroid therapy are based on the probable immune-mediated mechanism of toxic epidermal necrolysis and on small series in . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Beissert, S., Werfel, T., Frieling, U., Bohm, M., Sticherling, M., Stadler, R., Zillikens, D., Rzany, B., Hunzelmann, N., Meurer, M., Gollnick, H., Ruzicka, T., Pillekamp, H., Junghans, V., Luger, T. A. (2006). A Comparison of Oral Methylprednisolone Plus Azathioprine or Mycophenolate Mofetil for the Treatment of Pemphigus.. Arch Dermatol 142: 1447-1454 [Abstract] [Full Text]